FBInvestor
Stocks / Silence Therapeutics PLC
Institutional Ownership

Silence Therapeutics PLC

CUSIP 82686Q101ADSSLNQ1 2026

13D / 13G Filings
6
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
7.8%
Max % of class reported
Institutional Holders
56
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

6 filings · latest Nov 12, 2024

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Nov 12, 2024Invus Global Management, LLC13G/A5.3%7.44MSEC
2Aug 2, 2024Invus Global Management, LLC13G/A6.0%8.34MSEC
3Feb 12, 2024Goldman Sachs Group Inc13G/A2.2%2.32MSEC
4Feb 9, 2024Artal International S.C.A.13G/A7.8%9.00MSEC
5Sep 1, 2023Artal International S.C.A.13G6.8%7.50MSEC
6Feb 8, 2023Goldman Sachs Group Inc13G/A5.1%4.54MSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →